[1]
LINGABATHULA, S. and JAIN, N. 2021. STABILITY INDICATIVE AND COST EFFECTIVE ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF FAVIPIRAVIR AND PERAMIVIR IN BULK AND PHARMACEUTICAL DOSAGE FORM BY USING RP-HPLC. International Journal of Applied Pharmaceutics. 13, 4 (Jul. 2021), 265–271. DOI:https://doi.org/10.22159/ijap.2021v13i4.40530.